Adapting to Novel Hemophilia A Treatments

Russell P. Gollard, MD, FACP, highlights the impact of recent advances in hemophilia A treatment on formulary decisions and management approaches.

Related Keywords

Russellp Gollard , ,Hemophiliaa Treatment ,Advances In Therapy ,Formulary Decisions ,Management Approaches ,Novel Treatments ,Efficacy And Safety Data ,Clinical Trials ,Long Term Outcomes ,Patient Access ,Health Plan Response ,